# Visit Capture Dia/Heidi/GESY → Cockpit — independent R2 PASS received

> Date: 2026-10-08 Asia/Nicosia.
> Status: RECEIVED INDEPENDENT REVIEW RESULT / PASS / COMPLETE_FOR_DECLARED_SCOPE / P0:P1:P2 = 0:0:0.
> This is a coordinator receipt of the Product Owner-supplied independent review handback, not a newly conducted review.
> Reviewed exact branch head: `0f644d52307647b42ad2e845235531de8cf5e34d`.
> Verified main at review close: `045798dfa28612b268f16a99262c6ecc9ca4829d`.
> Delta design blob: `7e19ce29a3c33a0d06e6c0ec485952f41c0ecf72`.
> Delta request blob: `2e169a870d5ed04823c09d810f305dd3881defac`.
> Parent PASS receipt blob: `812cc4d80c98b0a6ab6afa8abf7f283c8e96bd61`.

## Received dispositions

- D1 PASS: extend existing internal patient, encounter and G3 owners; do not invent a second clinical truth store.
- D2 PASS: patient-bound capture-context and expected-version guards are required; current generic PUT is insufficient unchanged.
- D3 PASS: one structured encounter, three projections (Snapshot, Visit Brief, Encounter Detail).
- D4 PASS: current amended encounter PUT overwrites payload and does not preserve signed history; embedded step4.tasks are not first-class pending persistence. For first code server-enforce immutability after Visit Capture Save, and add only a minimal bounded first-class pending extension.
- D5 PASS: Heidi today / GESY today / previous GESY are distinct untrusted source roles; Dia inserts candidate; Cockpit confirms patient and clinician Save; live privacy qualification remains open.
- D6 PASS: **synthetic/manual-only first code**, no real provider or patient data.

## Narrow next implementation boundary — separate authority required

- One confirmed-patient `Καταγραφή επίσκεψης` surface.
- Transient validated `VisitCaptureCandidateV1` from synthetic/manual insertion.
- Server-issued patient/context guard, stale A→B rejection.
- One human-readable preview with all three projections from one normalized candidate.
- One clinician Save to existing protected `clinical_encounters`.
- Minimum separate pending persistence with responsible vs dependency distinction.
- Post-signoff mutation rejected server-side including via generic PUT; later amendment implementation deferred.
- Source refs/provenance without raw source-body persistence.
- Finite eight synthetic acceptance oracles from reviewed request.

Explicitly forbidden in this slice: live Dia, Heidi, GESY, Gmail, Zadarma, real patient data, lab result acceptance, booking/Calendar/Reception mutation, deploy or merge without separate release authority.

## Remaining live gates

Dia/Heidi/GESY processor/access policies; actual Dia tab-scoping and patient identity reliability; transient browser/cache/log handling; field-level retention/access/deletion policy; later integrations' own qualification.

## Closure rule

Independent delta pre-code review is CLOSED with no findings. No further reassurance review or correction is needed. Next action is a plain-language Product Owner first-code checkpoint and separate bounded implementation writer authorization under `CURRENT_OPERATIONAL.md`. The independent PASS alone does not grant implementation authority.
